"Trans-Activators" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Diffusible gene products that act on homologous or heterologous molecules of viral or cellular DNA to regulate the expression of proteins.
| Descriptor ID |
D015534
|
| MeSH Number(s) |
D12.776.260.755 D12.776.930.900 D12.776.964.925.984
|
| Concept/Terms |
Trans-Activators- Trans-Activators
- Trans Activators
- Transactivators
- Trans-Activator
- Trans Activator
- Transactivator
- Trans-Acting Factor
- Factor, Trans-Acting
- Trans Acting Factor
- Trans-Acting Factors
- Factors, Trans-Acting
- Trans Acting Factors
Nuclear Trans-Acting Factor- Nuclear Trans-Acting Factor
- Factor, Nuclear Trans-Acting
- Nuclear Trans Acting Factor
- Trans-Acting Factor, Nuclear
|
Below are MeSH descriptors whose meaning is more general than "Trans-Activators".
Below are MeSH descriptors whose meaning is more specific than "Trans-Activators".
This graph shows the total number of publications written about "Trans-Activators" by people in this website by year, and whether "Trans-Activators" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1993 | 1 | 0 | 1 |
| 1994 | 2 | 0 | 2 |
| 1995 | 3 | 1 | 4 |
| 1996 | 8 | 2 | 10 |
| 1997 | 2 | 0 | 2 |
| 1998 | 11 | 2 | 13 |
| 1999 | 18 | 1 | 19 |
| 2000 | 15 | 2 | 17 |
| 2001 | 15 | 5 | 20 |
| 2002 | 25 | 7 | 32 |
| 2003 | 13 | 6 | 19 |
| 2004 | 20 | 15 | 35 |
| 2005 | 17 | 8 | 25 |
| 2006 | 4 | 5 | 9 |
| 2007 | 8 | 6 | 14 |
| 2008 | 6 | 6 | 12 |
| 2009 | 10 | 4 | 14 |
| 2010 | 14 | 5 | 19 |
| 2011 | 2 | 6 | 8 |
| 2012 | 7 | 3 | 10 |
| 2013 | 11 | 4 | 15 |
| 2014 | 6 | 6 | 12 |
| 2015 | 4 | 3 | 7 |
| 2016 | 4 | 2 | 6 |
| 2017 | 2 | 3 | 5 |
| 2018 | 3 | 5 | 8 |
| 2019 | 4 | 1 | 5 |
| 2020 | 1 | 2 | 3 |
| 2021 | 0 | 2 | 2 |
| 2022 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Trans-Activators" by people in Profiles.
-
PU.1-Dependent Enhancer Inhibition Separates Tet2-Deficient Hematopoiesis from Malignant Transformation. Blood Cancer Discov. 2022 09 06; 3(5):444-467.
-
Whole-genome analysis of Nigerian patients with breast cancer reveals ethnic-driven somatic evolution and distinct genomic subtypes. Nat Commun. 2021 11 26; 12(1):6946.
-
Nonsense-mediated decay controls the reactivation of the oncogenic herpesviruses EBV and KSHV. PLoS Biol. 2021 02; 19(2):e3001097.
-
Another battle won in the phage-host arms race: Pseudomonas phage blocks quorum sensing regulator LasR. Mol Cell. 2021 02 04; 81(3):420-422.
-
Uncoupling histone H3K4 trimethylation from developmental gene expression via an equilibrium of COMPASS, Polycomb and DNA methylation. Nat Genet. 2020 06; 52(6):615-625.
-
Enhancer transcription identifies cis-regulatory elements for photoreceptor cell types. Development. 2020 02 05; 147(3).
-
MN1 C-terminal truncation syndrome is a novel neurodevelopmental and craniofacial disorder with partial rhombencephalosynapsis. Brain. 2020 01 01; 143(1):55-68.
-
The CAF-1 complex couples Hippo pathway target gene expression and DNA replication. Mol Biol Cell. 2019 11 01; 30(23):2929-2942.
-
Mucoepidermoid Carcinoma: A Comparison of Histologic Grading Systems and Relationship to MAML2 Rearrangement and Prognosis. Am J Surg Pathol. 2019 07; 43(7):885-897.
-
Imputed gene associations identify replicable trans-acting genes enriched in transcription pathways and complex traits. Genet Epidemiol. 2019 09; 43(6):596-608.